Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain ; volume:6 ; number:1 ; day:3 ; month:4 ; year:2018 ; pages:1-14 ; date:12.2018
Acta Neuropathologica Communications ; 6, Heft 1 (3.4.2018), 1-14, 12.2018
- Urheber
-
Dominguez, Gaëlle
- Beteiligte Personen und Organisationen
-
Maddelein, Marie-Lise
Pucelle, Mélanie
Nicaise, Yvan
Maurage, Claude-Alain
Duyckaerts, Charles
Cuvillier, Olivier
Delisle, Marie-Bernadette
SpringerLink (Online service)
- DOI
-
10.1186/s40478-018-0527-z
- URN
-
urn:nbn:de:101:1-2018060922000690593361
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dominguez, Gaëlle
- Maddelein, Marie-Lise
- Pucelle, Mélanie
- Nicaise, Yvan
- Maurage, Claude-Alain
- Duyckaerts, Charles
- Cuvillier, Olivier
- Delisle, Marie-Bernadette
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
Altered glycosylation profile of purified plasma ACT from Alzheimer’s disease
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders
Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
Altered DNA repair; an early pathogenic pathway in Alzheimer’s disease and obesity
Altered mitochondrial microenvironment at the spotlight of musculoskeletal aging and Alzheimer’s disease
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
Altered glycosylation profile of purified plasma ACT from Alzheimer’s disease
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders
Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
Altered DNA repair; an early pathogenic pathway in Alzheimer’s disease and obesity
Altered mitochondrial microenvironment at the spotlight of musculoskeletal aging and Alzheimer’s disease
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
Altered glycosylation profile of purified plasma ACT from Alzheimer’s disease
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders
Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
Altered DNA repair; an early pathogenic pathway in Alzheimer’s disease and obesity
Altered mitochondrial microenvironment at the spotlight of musculoskeletal aging and Alzheimer’s disease
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis